Hereditary alpha-1-antitrypsin deficiency and its clinical consequences - Wikidata - thesis-toulmin - TriplyDB

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

http://www.wikidata.org/entity/Q21202920

about

Stem cell-derived liver cells for drug testing and disease modeling Neonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and Treatment Flecainide and elevated liver enzymes in α1-antitrypsin deficiency Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study.Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German Registry.Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.Segmenting by risk perceptions: predicting young adults' genetic-belief profiles with health and opinion-leader covariates S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid Diagnosis of alpha-1-antitrypsin deficiency in bleeding disorder-related neonatal death.Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active The Z mutation alters the global structural dynamics of α1-antitrypsin.Biomarker analysis of Morquio syndrome: identification of disease state and drug responsive markers Conformational properties of the disease-causing Z variant of α1-antitrypsin revealed by theory and experiment.Identification of α1-Antitrypsin as a Potential Candidate for Internal Control for Human Synovial Fluid in Western Blot.The Diagnostic Value of Alpha-1-Antitrypsin Phenotype in Patients with Granulomatosis with Polyangiitis Metabolic investigations prevent liver transplantation in two young children with citrullinemia type I.α1-Antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in mice.Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.The effect of α1-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.Polymorphisms of α1-antitrypsin and Interleukin-6 genes and the progression of hepatic cirrhosis in patients with a hepatitis C virus infection.An update on laboratory diagnosis of liver inherited diseases.Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models.Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective.Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management.Protease-activated receptors and their biological role - focused on skin inflammation.Utilization of Positive and Negative Controls to Examine Comorbid Associations in Observational Database Studies.Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.Pulmonary vasculature directed adenovirus increases epithelial lining fluid alpha-1 antitrypsin levels.Fibrinogen and α1-antitrypsin in COPD exacerbations.Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.An RNA structure-mediated, posttranscriptional model of human α-1-antitrypsin expression.The Role of Computed Tomography for the Evaluation of Lung Disease in Alpha-1 Antitrypsin Deficiency.Bioequivalence of a Liquid Formulation of Alpha1-Proteinase Inhibitor Compared with Prolastin®-C (Lyophilized Alpha1-PI) in Alpha1-Antitrypsin Deficiency.The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.A patient with the rare alpha-1-antitrypsin variant (Z)bristol in compound heterozygosity with the Z mutation.Knockdown of Z Mutant Alpha-1 Antitrypsin In Vivo Using Modified DNA Antisense Oligonucleotides.Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

P2860

Q27012605-C1BD0610-46D8-4FF4-90B5-8829CCC49496 Q28083869-CDDF52B8-D2EA-460A-9463-2AF448C4673E Q33643591-92A72F72-D6E2-4B74-B3A1-C70ED5C5C2B9 Q33710034-54B0229D-742A-4CC1-8610-EEBF10DC8322 Q33713789-5EE57377-7CA5-4E54-AA0F-6FA507FB65A9 Q33743024-4463165C-BF51-47C6-942D-9696363CDA34 Q33773666-0C747A71-767E-473F-91B8-7F55D1065EE0 Q34244767-5728D053-7777-4821-9841-698A4DF2C941 Q34325994-F908031C-653E-4B53-9B44-34093520C86F Q34467481-752CC5F4-E363-4902-B5D4-43494C427CC5 Q35019400-5F6CEF07-3A57-4E39-93B2-C86B772BB56D Q35236899-FA2093DA-2A90-4842-A7EC-1D4275E92A14 Q35759053-D065E988-A463-480C-8A7A-2F33D69861BA Q36045474-3ECB6549-F8C7-42F5-AA81-67E906E46169 Q36292289-13932943-1E91-4264-92BA-B7E345815C90 Q36809810-8478A83F-2D2C-4935-9FDE-305E321BDE21 Q37132291-E2BB4925-1851-44F7-AA87-5A0F07759D25 Q37313010-AD4BFF08-D97D-4710-B16D-B2A4A4593CA6 Q37396256-C0D24A6C-3BD3-4460-8FBA-4A282A4E06B1 Q37410088-BFA1DE6E-4045-4EF0-94DA-E324B71C9C60 Q37410570-D08A1E7C-62D8-4535-969F-0D9E458FAA9B Q37689986-470874C7-5851-45DB-84CC-E13675A83EA5 Q38162187-E336A79D-3634-422C-BAE7-37260747A0E3 Q38165139-AA5313ED-CBA8-40FC-8584-A00C196A54C2 Q38283014-FF085600-21CE-45CB-87CE-386E9FD9080A Q38457176-0A7B46F5-7094-4E87-9124-9AA6C8375FF6 Q38680840-D2CE088A-9219-4217-A20E-A6EEAD68EAF3 Q39244414-6F21E4CD-3969-41BE-A426-56235BF871A7 Q40210745-46BB317F-66BB-4BBF-9AD2-4534540C024C Q40941530-8F8A3A1C-9EC6-4A61-B955-A18FF0618318 Q41454775-4609D273-E7E1-4D3C-8A93-43927DE76AE7 Q41894323-76FD78B1-4EF3-4F16-AEE9-25E60AD4F73A Q47162066-E59B669C-5BE5-4121-851A-5638C6F0BB64 Q47659859-433E5D95-EFF6-4439-8B50-AA35AED783B5 Q47677150-63D5DB3F-DCAC-4136-8C3F-7B028740D895 Q47683303-D5096B28-90AE-4725-94D5-DE3A4E93E95B Q47999752-C1CAE167-6537-4443-AFF2-AC9895E1A177 Q48018036-6DFC913C-7AEA-4DB9-91D7-3CFF1140E9AB Q49437744-BE2E53E4-C735-4802-9FCF-72C054618548 Q55666746-7B4B50DA-1949-4BA8-9020-440E2A7F77C7

P2860

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

http://www.wikidata.org/entity/Q21202920

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@ast

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@en

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@en-gb

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@nl

type

label

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@ast

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@en

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@en-gb

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@nl

prefLabel

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@ast

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@en

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@en-gb

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@nl

P1433

Q21202920-73BBC8A5-407B-453B-ADF1-DE09AA96C312

P1476

Q21202920-CCDF43EC-BF85-485A-835A-E781D402EA93

P2093

Q21202920-F1B4492D-55BB-4622-96DD-D101984BE0B7

Q21202920-F98890B4-015B-4877-B707-B039DB96634B

P275

Q21202920-3C9ADE5D-8F46-4140-84C4-C2AFCD03BFAE

P2860

Q21202920-2BE77757-8609-4396-BEAB-1F283BAD4BB3

Q21202920-374260FF-4038-4FC8-8CD9-3FA9A5CD4939

Q21202920-460F445B-23B7-47FA-939F-345290E5DEDA

Q21202920-469F4BE8-0346-45CC-9CD9-2BBA8609B1E1

Q21202920-62B095C4-8E0C-4614-84AB-98A50614ED09

Q21202920-6625579F-0A21-4DEE-93D9-57F78E0EF0E4

Q21202920-7582F38F-039F-44FE-AB68-574D47B54E41

Q21202920-77767D98-E0F5-4447-A3C8-BA5C7B39CA11

Q21202920-7CF0CEB8-75F2-4258-9205-9D2A741650A7

Q21202920-8B30929A-88CB-40D0-B61D-ADEA4107EFE3

P2888

Q21202920-7E7A28F8-B87F-4821-879A-BFB1858FA1D3

P304

Q21202920-9823B405-E19D-4F75-B833-0BE997B32A80

P31

Q21202920-9BF46C90-B9DB-4B53-81D1-0FACED6DD4AD

Q21202920-CC3638EF-C82D-4205-889C-FB2513BD9997

P3181

Q21202920-BF2A74C1-8F60-4E18-BB40-AEB2E549697A

P356

Q21202920-D14C2A9F-BC05-44FC-AC78-6B50793090F6

P407

Q21202920-ED44D453-3EB8-44D8-BE24-16FD9B611459

P433

Q21202920-A4D510D2-B954-4BBC-A484-16CF9455C4AB

P478

Q21202920-67A9C4CA-4031-4860-9DEF-F1B82C0C8F38

P5008

Q21202920-D03202B4-FD5E-4FED-88F3-F19760967FC7

P577

Q21202920-FE4C65C3-9F9F-46DC-A4F4-4511CD2A4A11

P5875

Q21202920-06FA8DA7-9085-49DA-A2AD-5AFD984902B7

P6179

Q21202920-52B256A5-93D1-4A46-8E16-404E3A6DC3EB

P698

Q21202920-C3695706-0ED3-4CBD-AAF2-6C2551357A25

P921

Q21202920-21BB51F1-3AF6-4FA5-8AA4-2DFEA8805C39

Q21202920-4E29CBD8-ABC0-4C28-829A-30F12C85D87D

Q21202920-7950A54A-8040-45BC-8605-3D0DB84029FD

Q21202920-A0D352F8-833E-486D-A7C3-1F543B5A3856

Q21202920-A71B233C-AC3B-45A1-807A-DBEFE74FDB39

Q21202920-C4EF8A28-5DBC-40C9-B90D-18298312AE2E

P932

Q21202920-13216990-89AD-4BFE-9C1D-01B3B8146CDF

P3181

P356

P1433

Orphanet Journal of Rare Diseases

P1476

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

@en

P2093

Jan Stolk

http://www.w3.org/2001/XMLSchema#string

Laura Fregonese

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin

Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma

The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. 1963.

Alpha1-antitrypsin deficiency--a model for conformational diseases.

Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.

Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.

Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency.

Predictors of mortality in alpha1-antitrypsin deficiency

Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo

P2888

P304

16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2396800

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1750-1172-3-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2008-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5289825

http://www.w3.org/2001/XMLSchema#string

P6179

1053473059

http://www.w3.org/2001/XMLSchema#string

P698

18565211

http://www.w3.org/2001/XMLSchema#string

P921

alpha-1-antitrypsin deficiency

liver cirrhosis

pulmonary emphysema

P932

2441617

http://www.w3.org/2001/XMLSchema#string